27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report issued Tuesday, Roth Capital Partners analysts Elemer Piros takes a quick look at Spark Therapeutics Inc (NASDAQ: ONCE) ahead of its lock-up expiration, which will take place on Wednesday -- up to 16.5 million restricted shares could become freely tradeable then.
Related Link: Heads-Up Spark Therapeutics Investors: 4 Wall Street Firms Are Now Bullish
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The expert issued a Buy rating and $71.00 12-month price target for the shares, noting that any potential pressure on them would represent an attractive entry point for investors.
Value Drivers
Spark will soon announce the results from a pivotal gene therapy trial for an inherited retinal dystrophy (IRD) addressed by SPK-RPE65. Roth estimates that this product has an associated market potential of $250 million.
The report explains that, “While the peak sales estimates for Spark's other programs are multiples of the initial IRD, SPK-RPE65 represents a precedent on both developmental and regulatory fronts. There are more than 200 gene mutations identified to cause IRDs.”
Related Link: Why Gene Therapy Is The Best Bet For Restoring Functional Vision
Moreover, Piros notes, the company’s pipeline is advancing. In the first half of the year, the company treated the first patients suffering from choroideremia, another IRD. Spark and Pfizer Inc. (NYSE: PFE) also started, in partnership, a trial in hemophilia B. The expert concludes that, “With >$200MM in the bank, Spark is an enviable position to expeditiously develop the current and yet unannounced members of its pipeline.”
Spark shares are up about 2 percent on Tuesday trading.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.